Abstract
Several studies have shown that Helicobacter pylori eradication rates with standard 7-day triple therapy are unsatisfactory. A novel 10-day sequential treatment regimen recently achieved a significantly higher eradication rate. To improve the pharmacotherapeutic cost, we evaluated whether an acceptable eradication rate could be achieved in peptic ulcer patients by halving the dose of clarithromycin.
Original language | English |
---|---|
Pages (from-to) | 641-646 |
Number of pages | 6 |
Journal | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Volume | 18 |
Publication status | Published - 2003 |
Externally published | Yes |
Keywords
- 2-Pyridinylmethylsulfinylbenzimidazoles
- Adult
- Aged
- Amoxicillin
- Antacids
- Anti-Ulcer Agents
- Benzimidazoles
- Clarithromycin
- Cost-Benefit Analysis
- Drug Costs
- Drug Therapy, Combination
- Duodenal Ulcer
- Female
- Helicobacter Infections
- Helicobacter pylori
- Humans
- Male
- Middle Aged
- Omeprazole
- Prospective Studies
- Tinidazole
- Treatment Outcome